Efficacy and Safety of Linagliptin Co-Administered with Low-Dose Metformin Once Daily Versus High-Dose Metformin Twice Daily in Treatment-Naïve Patients with Type 2 Diabetes: a Dou...

por Ji, Linong, Zinman, Bernard, Patel, Sanjay, Ji, Jinfeng, Bailes, Zelie, Thiemann, Sandra, Seck, Thomas
Publicado 2015

A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids

por Kerwin, Edward, Pascoe, Steven, Bailes, Zelie, Nathan, Robert, Bernstein, David, Dahl, Ronald, von Maltzahn, Robyn, Robbins, Kevin, Fowler, Andrew, Lee, Laurie
Publicado 2020

Measuring respiratory symptoms in moderate/severe asthma: evaluation of a respiratory symptom tool, the E-RS®: COPD in asthma populations

por Tabberer, Maggie, von Maltzahn, Robyn, Bacci, Elizabeth D., Karn, Hayley, Hsieh, Ray, Howell, Timothy A., Bailes, Zelie, Fowler, Andrew, Lee, Laurie, Murray, Lindsey T.
Publicado 2021

Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hypergly...

por Ma, Ronald CW, Del Prato, Stefano, Gallwitz, Baptist, Shivane, Vyankatesh K, Lewis‐D'Agostino, Diane, Bailes, Zelie, Patel, Sanjay, Lee, Jisoo, von Eynatten, Maximilian, Di Domenico, Maximiliano, Ross, Stuart A
Publicado 2017